Marmar Vaseghi1, Jean Gima2, Christopher Kanaan2, Olujimi A Ajijola2, Alexander Marmureanu3, Aman Mahajan4, Kalyanam Shivkumar2. 1. UCLA Cardiac Arrhythmia Center, Los Angeles, California. Electronic address: mvaseghi@mednet.ucla.edu. 2. UCLA Cardiac Arrhythmia Center, Los Angeles, California. 3. UCLA Cardiac Arrhythmia Center, Los Angeles, California; Division of Cardiothoracic Surgery, Los Angeles, California. 4. UCLA Cardiac Arrhythmia Center, Los Angeles, California; Department of Anesthesiology, UCLA Health System, Los Angeles, California.
Abstract
BACKGROUND: Left and bilateral cardiac sympathetic denervation (CSD) have been shown to reduce burden of ventricular arrhythmias acutely in a small number of patients with ventricular tachyarrhythmia (VT) storm. The effects of this procedure beyond the acute setting are unknown. OBJECTIVE: The purpose of this study was to evaluate the intermediate and long-term effects of left and bilateral CSD in patients with cardiomyopathy and refractory VT or VT storm. METHODS: Retrospective analysis of medical records for patients who underwent either left or bilateral CSD for VT storm or refractory VT between April 2009 and December 2012 was performed. RESULTS: Forty-one patients underwent CSD (14 left CSD, 27 bilateral CSD). There was a significant reduction in the burden of implantable cardioverter-defibrillator (ICD) shocks during follow-up compared to the 12 months before the procedure. The number of ICD shocks was reduced from a mean of 19.6 ± 19 preprocedure to 2.3 ± 2.9 postprocedure (P < .001), with 90% of patients experiencing a reduction in ICD shocks. At mean follow-up of 367 ± 251 days postprocedure, survival free of ICD shock was 30% in the left CSD group and 48% in the bilateral CSD group. Shock-free survival was greater in the bilateral group than in the left CSD group (P = .04). CONCLUSION: In patients with VT storm, bilateral CSD is more beneficial than left CSD. The beneficial effects of bilateral CSD extend beyond the acute postsympathectomy period, with continued freedom from ICD shocks in 48% of patients and a significant reduction in ICD shocks in 90% of patients.
BACKGROUND: Left and bilateral cardiac sympathetic denervation (CSD) have been shown to reduce burden of ventricular arrhythmias acutely in a small number of patients with ventricular tachyarrhythmia (VT) storm. The effects of this procedure beyond the acute setting are unknown. OBJECTIVE: The purpose of this study was to evaluate the intermediate and long-term effects of left and bilateral CSD in patients with cardiomyopathy and refractory VT or VT storm. METHODS: Retrospective analysis of medical records for patients who underwent either left or bilateral CSD for VT storm or refractory VT between April 2009 and December 2012 was performed. RESULTS: Forty-one patients underwent CSD (14 left CSD, 27 bilateral CSD). There was a significant reduction in the burden of implantable cardioverter-defibrillator (ICD) shocks during follow-up compared to the 12 months before the procedure. The number of ICD shocks was reduced from a mean of 19.6 ± 19 preprocedure to 2.3 ± 2.9 postprocedure (P < .001), with 90% of patients experiencing a reduction in ICD shocks. At mean follow-up of 367 ± 251 days postprocedure, survival free of ICD shock was 30% in the left CSD group and 48% in the bilateral CSD group. Shock-free survival was greater in the bilateral group than in the left CSD group (P = .04). CONCLUSION: In patients with VT storm, bilateral CSD is more beneficial than left CSD. The beneficial effects of bilateral CSD extend beyond the acute postsympathectomy period, with continued freedom from ICD shocks in 48% of patients and a significant reduction in ICD shocks in 90% of patients.
Authors: William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger Journal: N Engl J Med Date: 2002-06-13 Impact factor: 91.245
Authors: Seongwook Han; Kenzaburo Kobayashi; Boyoung Joung; Gianfranco Piccirillo; Mitsunori Maruyama; Harry V Vinters; Keith March; Shien-Fong Lin; Changyu Shen; Michael C Fishbein; Peng-Sheng Chen; Lan S Chen Journal: J Am Coll Cardiol Date: 2012-03-06 Impact factor: 24.094
Authors: John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: Olujimi A Ajijola; Robert L Lux; Anadjeet Khahera; OhJin Kwon; Eric Aliotta; Daniel B Ennis; Michael C Fishbein; Jeffrey L Ardell; Kalyanam Shivkumar Journal: Am J Physiol Heart Circ Physiol Date: 2017-01-13 Impact factor: 4.733
Authors: Veronica Dusi; Leila Shahabi; Rachel C Lapidus; Julie M Sorg; Bruce D Naliboff; Kalyanam Shivkumar; Sahib S Khalsa; Olujimi A Ajijola Journal: Heart Rhythm Date: 2020-04-20 Impact factor: 6.343
Authors: Olujimi A Ajijola; Daigo Yagishita; Naveen K Reddy; Kentaro Yamakawa; Marmar Vaseghi; Anthony M Downs; Donald B Hoover; Jeffrey L Ardell; Kalyanam Shivkumar Journal: Heart Rhythm Date: 2015-01-30 Impact factor: 6.343
Authors: Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld Journal: J Interv Card Electrophysiol Date: 2020-10 Impact factor: 1.900
Authors: Richard S Shelton; Masahiro Ogawa; Hongbo Lin; Changyu Shen; Johnson Wong; Shien-Fong Lin; Peng-Sheng Chen; Thomas H Everett Journal: JACC Clin Electrophysiol Date: 2018-03-28